Wearable Monitoring Device in Daily Lives of Community-dwelling Older Adults
- Conditions
- Device Ineffective
- Interventions
- Device: Live With Wearable Monitoring Device program
- Registration Number
- NCT05269303
- Lead Sponsor
- The Hong Kong Polytechnic University
- Brief Summary
The aim is to implement an intervention program to promote the continued use of Wearable Monitoring Devices among older adults through a peer support approach facilitating the incorporation of Wearable Monitoring Devices in daily life.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 72
- aged 60 or above
- own a smartphone
- able to communicate in Cantonese or Mandarin
- able to access the Internet at home or elsewhere
- have a confirmed diagnosis of cognitive impairment
- bed-bound
- currently own a wearable monitoring device
- have already engaged in other wearable device studies
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention group Live With Wearable Monitoring Device program Participants will receive a 3-month Live With Wearable Monitoring Device program.
- Primary Outcome Measures
Name Time Method The change of use intention of wearable monitoring device Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points It will be measured using a 4-item, 5-point Likert scale adopted from Bhattacherjee (2001) and Windasari et al. (2021). The five-point scale ranges from 1 = not at all satisfied to 5 = very certain, with higher scores representing a higher chance of continuing to use the WMD.
- Secondary Outcome Measures
Name Time Method The change of health service utilization among baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points ealth service utilization includes the number of attendances at a general practitioner's office, emergency department, hospital, and general out-patient clinic. The data will be reported by the participants and confirmed with medical and attendance certificates
The change of adherence rate of wearing wearable monitoring device Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points It will be measured by checking in our database the number of days that participants wore their device, and the average amount of time worn per day. Longer time worn represents better adherence rate
The change in quality of life among baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points Quality of life will be measured using the Hong Kong version of the EuroQol 5-dimension scale. The EQ-5D-5L is comprised of five dimensions, namely, mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. The utility score ranges from 0 to 1, with higher means better quality of life
Recruitment rate baseline pre-intervention The recruitment rate will be calculated by dividing the number of participants who are recruited and randomized, by the number of eligible participants.
Incidence of reports of adverse events 6-month (T3) time points the incidence of reports of adverse events will be recorded by a staff member assigned to each of the community centres and a nurse
Incidence of reports of technical difficulties 6-month (T3) time points Incidence of reports of technical difficulties will be recorded by a staff member assigned to each of the community centres and a nurse
Attrition rate 6-month (T3) time points The attrition rate refers to the number of participants who withdraw from the study or who are lost to follow up.
The change of perceived usability of the wearable monitoring device before and after the program baseline pre-intervention, 6-month (T3) time points The participants will be required to complete a questionnaire that measures their attitude towards using the WMD; the perceived usefulness, perceived ease of use, and self-efficacy of using the device; and their level of anxiety about using the device. The questionnaire was drawn up by Chen and Chan (2014). This 10-point Likert scale ranges from 1 (strongly disagree) to 10 (strongly agree), with higher marks indicating a better outcome, with the exception of the item on anxiety levels, where higher marks represent a higher level of anxiety in using the WMD.
Trial Locations
- Locations (1)
Siu Sai Wan
ðŸ‡ðŸ‡°Hong Kong, Hong Kong